MedTrace Logo

Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

NCT03030430 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2018-07-30

No results posted yet for this study

Summary

The purpose of this study is to establish PK similarity in the treatment of BAT1706 and comparators.

Conditions

Interventions

BIOLOGICAL

BAT1706 injection

1mg/kg, IV on day 1

BIOLOGICAL

EU-sourced Avastin

1mg/kg, IV on day 1

BIOLOGICAL

US-sourced Avastin

1mg/kg, IV on day 1

Sponsors & Collaborators

Principal Investigators

  • Chris Wynne, Medical Doc · Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-15
Primary Completion
2017-05-16
Completion
2017-06-28

Countries

  • New Zealand

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03030430 on ClinicalTrials.gov